Central nervous system stimulants and drugs that suppress appetite

Nicholas T. Bello, Dushyant Kshatriya

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

The Side Effects of Drugs Annuals form a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. The purpose of this supplement is to provide a concise reference of the newly available literature to support the existing information regarding the known adverse effects of commonly prescribed medications or abused drugs. The information covers peer-reviewed publications from January 2018 to December 2018. This review focused on CNS stimulants and drugs that suppress appetite. It covers amphetamines (including lisdexamfetamine, methamphetamine and 3,4-methylenedioxymetamphetamine), methylphenidate, atomoxetine, modafinil and armodafinil, suvorexant, methylxanthines (caffeine), monotherapies and combinational therapies that suppress appetite (phentermine, phentermine/topiramate) and medications used in Alzheimer's disease and cognitive decline (rivastigmine, donepezil and memantine).

Original languageEnglish (US)
Title of host publicationA Worldwide Yearly Survey of New Data in Adverse Drug Reactions
EditorsSidhartha D. Ray
PublisherElsevier B.V.
Pages1-11
Number of pages11
ISBN (Print)9780128171639
DOIs
StatePublished - 2019

Publication series

NameSide Effects of Drugs Annual
Volume41
ISSN (Print)0378-6080

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug guides
  • Pharmacology (medical)

Keywords

  • Adverse reactions
  • Alzheimer's disease
  • Amfetamine
  • Amphetamines
  • Appetite suppressants
  • Armodafinil
  • Atomoxetine
  • Caffeine
  • Donepezil
  • Galantamine
  • Lisdexamfetamine
  • Memantine
  • Metamfetamine
  • Methylphenidate
  • Methylxanthines
  • Modafinil
  • Phentermine
  • Rivastigmine
  • Treatment emergent adverse effects

Fingerprint

Dive into the research topics of 'Central nervous system stimulants and drugs that suppress appetite'. Together they form a unique fingerprint.

Cite this